| Dr Christina Dibartolomeo Boswell, DO | |
|
3609 Park East Dr Ste 207, Beachwood, OH 44122-4309 | |
| (216) 360-0456 | |
| (216) 360-9449 |
| Full Name | Dr Christina Dibartolomeo Boswell |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 9 Years |
| Location | 3609 Park East Dr Ste 207, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972031037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 34.013824 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Hospital | Mayfield heights, OH | Hospital |
| University Hospitals Ahuja Medical Center | Beachwood, OH | Hospital |
| Cleveland Clinic | Cleveland, OH | Hospital |
| Lake Health | Concord, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Id Consultants Of Northeast Ohio Inc | 1355747882 | 17 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.
A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.
And in Georgia, protesters who had conducted a "sit in" at Gov. Nathan Deal's office to press him to accept a letter urging expansion of the state's Medicaid program, are arrested.
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
› Verified 7 days ago
| Entity Name | Id Consultants, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124058920 PECOS PAC ID: 7012995574 Enrollment ID: O20040711000002 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.
A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.
And in Georgia, protesters who had conducted a "sit in" at Gov. Nathan Deal's office to press him to accept a letter urging expansion of the state's Medicaid program, are arrested.
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
› Verified 7 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.
A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.
And in Georgia, protesters who had conducted a "sit in" at Gov. Nathan Deal's office to press him to accept a letter urging expansion of the state's Medicaid program, are arrested.
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
› Verified 7 days ago
| Entity Name | Id Consultants Of Northeast Ohio Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255913117 PECOS PAC ID: 1355747882 Enrollment ID: O20210909001394 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.
A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.
And in Georgia, protesters who had conducted a "sit in" at Gov. Nathan Deal's office to press him to accept a letter urging expansion of the state's Medicaid program, are arrested.
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christina Dibartolomeo Boswell, DO 3609 Park East Dr Ste 207, Beachwood, OH 44122-4309 Ph: (216) 360-0456 | Dr Christina Dibartolomeo Boswell, DO 3609 Park East Dr Ste 207, Beachwood, OH 44122-4309 Ph: (216) 360-0456 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.
A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.
And in Georgia, protesters who had conducted a "sit in" at Gov. Nathan Deal's office to press him to accept a letter urging expansion of the state's Medicaid program, are arrested.
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
› Verified 7 days ago
Lisa E Meek, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3737 Park East Dr Ste 109, Beachwood, OH 44122 Phone: 216-464-7333 Fax: 216-464-2696 | |
Mark N Rakowsky, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 4110 Warrensville Center Rd, Beachwood, OH 44122 Phone: 216-491-6000 | |
Dr. Raja Shekar, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3609 Park East Dr, 207, Beachwood, OH 44122 Phone: 216-360-0456 Fax: 216-360-9449 | |
Dr. Cynthia Gustaferro, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3609 Park East Dr, 207, Beachwood, OH 44122 Phone: 216-360-0456 Fax: 216-360-9449 | |
Scott L Massien, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Auburn Dr # 110, Beachwood, OH 44122 Phone: 216-285-5050 Fax: 216-285-4044 | |
William Michael Wolf, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3999 Richmond Rd, Harrington Heart And Vascular Institute, Beachwood, OH 44122 Phone: 216-593-1303 Fax: 216-593-1301 | |
Dr. Prateek Mendiratta, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 26900 Cedar Rd, 330-s, Beachwood, OH 44122 Phone: 216-839-2990 Fax: 216-839-2975 |